Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Nawaz, Mohd.
- Evaluation of Differential Levels of Serum Interleukin-6 in Pre-Eclamptic and Normal Pregnancy Women
Abstract Views :433 |
PDF Views:0
Authors
Affiliations
1 Hind Institute of Medical Sciences, Safedabad, Barabanki, IN
2 Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow, IN
1 Hind Institute of Medical Sciences, Safedabad, Barabanki, IN
2 Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow, IN
Source
International Journal of Physiology, Vol 8, No 1 (2020), Pagination: 53-56Abstract
There has been an increase incidence of Pre eclampsia which is one of the important causes of maternal as well as foetal mortality and morbidity. The changing life style and various stresses in this fast growing world further increase the incidence of Pre eclampsia. The exact cause is still not known beside exploratory study but it seems a state of inflammatory and oxidative stress. Our aim was to evaluate the role of Interleukin 6 (IL6) and to compare its value in normal pregnancy and pre eclampsia. We found in this study that level of IL6 is significantly high in pre-eclamptic compare to normal pregnant women. Our study shows that Preeclampsia pregnancy is associated with an enhanced maternal inflammatory condition.Keywords
Pre Eclampsia, Interleukin-6, Inflammatory, Oxidative Stress, Mortality, Pregnancy.
References
- Magee LA, Pels A, et al. Canadian Hypertensive Disorders of Pregnancy Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. 2014.
- Roberts JM, Lain KY et. al: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002,
- Duley L. The Global Impact of Pre-eclampsia and Eclampsia. SeminPerinatol. 2009;33(3):130
- Villar J, Say L, Gulmezoglu AM, Meraldi M, et. al; Eclampsia and preeclampsia: a health problem for 2000 years.
- Kuklina EV, et al. Hypertensive Disorders and Severe Obstetric Morbidity in the United States. ObstetGynecol 2009.
- Gupta P., O. P. Ghai. Common complications of pregnancy. In: P. Gupta, O. P. Ghai, eds. Preventive and Social Medicine. 2nd ed. New Delhi, India: CBS Publications; 1998.
- Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta.2009
- Walker JJ: Pre-eclampsia. Lancet 2000; 356:1260–1265. National High Blood Pressure Education Programme Working Group Pediatrics, 2004
- Hayashi M, Ueda Y, et al. Interleukin6concentrations in the placentaand blood in normal pregnancies and preeclampsia. HormMetab Res. 2005;37:419 24.
- Hirano, T., Yasukawa, K., Harada, H., et al., 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.
- Ishihara, K., Hirano, T., 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13, 357– 368
- Erzen B, Sabovic M, et al. Poredos P:pre-eclamptic pregnancies,” Gynecological Endocrinology, vol. 24, no. 3, pp. 113–116, 2008.
- Singh A, Bhattacharjee J. et al. Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of preeclampsia. Am J ReprodImmunol 2010.
- Kalinderis M, et al. Elevated serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclampsia. Am J ReprodImmunol. 2011
- Arjunjain et. al on Hypoxic treatment of human paplacental perfusion 2014.
- Cristina et al. 2011. Ïnflammatory disturbances in pre-eclampsia.
- Sharma A, Satyam A, Sharma JB. Leptin, IL-10, and inflammatory markers (TNF-alpha, IL-6 and IL-8) in preeclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol.2007;58(1):21–30.
- Nilsson MB, Langley RR, Fidler IJ. Interleukin6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 2005 PubMed.
- Tosun M., H. Celik, B. Avci, E. et al., “Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia,” 2010.
- Desai TR, Leeper NJ, Hynes KL, et. al, Interleukin6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118–23.
- Maruo N, Morita I, Ishizaki Y, et al. Inhibitory effects of interleukin 6 on prostaglandin I2 production in cultured bovine vascular Maria IrenoRebelo, Jose Manuel, Nieto Villar. Heart rate variability analysis during normal and hypertensive pregnancy: Dissertation of University of Porto, 2010. . ;PubMed
- Desai TR, Leeper NJ, Hynes KL, et. al, Interleukin6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118–23.
- S. Al-Othman, A. E. Omu, F. M. E. Diejomaoh, M. Al-Yatama, and F. Al-Qattan, “Differential levels of interleukin 6 in maternal and cord sera and placenta in women with pre-eclampsia,” Gynecologic and Obstetric Investigation, vol. 52, no. 1, pp. 60–65, 2001
- M. Montagnana, G. Lippi, A. Albiero, G. L. Salvagno, M. Franchi, and G. C. Guidi, “Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies,” Gynecological Endocrinology, vol. 24, no. 3, pp. 113–116, 2008